Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate CancerZeda Zhang, Charles L. Sawyers, Young Sun Lee et al.|Cancer Cell|2020Cited by 252
Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistanceSu Deng, Ping Mu|Nature Cancer|2022Cited by 148
Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancerXiaoling Li, Ping Mu|Cancer Cell|2023Cited by 47
UBE2J1 is the E2 ubiquitin-conjugating enzyme regulating androgen receptor degradation and antiandrogen resistanceCarla R. Tirado, Ping Mu|Oncogene|2023Cited by 17
RUNX1T1-HDAC Reprogramming of the HOX Code Signaling Drives a Targetable Pan-Cancer Lineage PlasticityYuyin Jiang, Ping Mu|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1